MicroRNA pathways modulate polyglutamine-induced neurodegeneration

被引:210
|
作者
Bilen, Julide
Liu, Nan
Burnett, Barrington G.
Pittman, Randall N.
Bonini, Nancy M. [1 ]
机构
[1] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA
[2] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
关键词
D O I
10.1016/j.molcel.2006.07.030
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nine human neurodegenerative diseases are due to expansion of a CAG repeat-encoding glutamine within the open reading frame of the respective genes. Polyglutamine (polyQ) expansion confers dominant toxicity, resulting in neuronal degeneration. MicroRNAs (miRNAs) have been shown to modulate programmed cell death during development. To address whether miRNA pathways play a role in neurodegeneration, we tested whether genes critical for miRNA processing modulated toxicity induced by the spinocerebellar ataxia type 3 (SCA3) protein. These studies revealed a striking enhancement of polyQ toxicity upon reduction of miRNA processing in Drosophila and human cells. In parallel genetic screens, we identified the miRNA bantam (ban) as a potent modulator of both polyQ and tau toxicity in files. Our studies suggest that ban functions downstream of toxicity of the SCA3 protein, to prevent degeneration. These findings indicate that miRNA pathways dramatically modulate poIyQ- and tau-induced neurodegeneration, providing the foundation for new insight into therapeutics.
引用
收藏
页码:157 / 163
页数:7
相关论文
共 50 条
  • [1] Experimental Models for Identifying Modifiers of Polyglutamine-Induced Aggregation and Neurodegeneration
    Calamini, Barbara
    Lo, Donald C.
    Kaltenbach, Linda S.
    NEUROTHERAPEUTICS, 2013, 10 (03) : 400 - 415
  • [2] Experimental Models for Identifying Modifiers of Polyglutamine-Induced Aggregation and Neurodegeneration
    Barbara Calamini
    Donald C. Lo
    Linda S. Kaltenbach
    Neurotherapeutics, 2013, 10 : 400 - 415
  • [3] The influence of protein nucleocytoplasmic transport on expanded polyglutamine-induced neurodegeneration
    Chan, Wing Man
    Shaw, Pang Chui
    Chan, Ho Yin Edwin
    FASEB JOURNAL, 2008, 22
  • [4] RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia
    Xia, HB
    Mao, QW
    Eliason, SL
    Harper, SQ
    Martins, IH
    Orr, HT
    Paulson, HL
    Yang, L
    Kotin, RM
    Davidson, BL
    NATURE MEDICINE, 2004, 10 (08) : 816 - 820
  • [5] RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia
    Haibin Xia
    Qinwen Mao
    Steven L Eliason
    Scott Q Harper
    Inês H Martins
    Harry T Orr
    Henry L Paulson
    Linda Yang
    Robert M Kotin
    Beverly L Davidson
    Nature Medicine, 2004, 10 : 816 - 820
  • [6] Identification of ter94, Drosophila VCP, as a modulator of polyglutamine-induced neurodegeneration
    H Higashiyama
    F Hirose
    M Yamaguchi
    Y H Inoue
    N Fujikake
    A Matsukage
    A Kakizuka
    Cell Death & Differentiation, 2002, 9 : 264 - 273
  • [7] Identification of ter94, Drosophila VCP, as a modulator of polyglutamine-induced neurodegeneration
    Higashiyama, H
    Hirose, F
    Yamaguchi, M
    Inoue, YH
    Fujikake, N
    Matsukage, A
    Kakizuka, A
    CELL DEATH AND DIFFERENTIATION, 2002, 9 (03): : 264 - 273
  • [8] DNA methylation inhibitor attenuates polyglutamine-induced neurodegeneration by regulating Hes5
    Kondo, Naohide
    Tohnai, Genki
    Sahashi, Kentaro
    Iida, Madoka
    Kataoka, Mayumi
    Nakatsuji, Hideaki
    Tsutsumi, Yutaka
    Hashizume, Atsushi
    Adachi, Hiroaki
    Koike, Haruki
    Shinjo, Keiko
    Kondo, Yutaka
    Sobue, Gen
    Katsuno, Masahisa
    EMBO MOLECULAR MEDICINE, 2019, 11 (05)
  • [9] RACK1 modulates polyglutamine-induced neurodegeneration by promoting ERK degradation in Drosophila
    Xie, Jun
    Han, Yongchao
    Wang, Tao
    PLOS GENETICS, 2021, 17 (05):
  • [10] Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice
    Zu, T
    Duvick, LA
    Kaytor, MD
    Berlinger, MS
    Zoghbi, HY
    Clark, HB
    Orr, HT
    JOURNAL OF NEUROSCIENCE, 2004, 24 (40): : 8853 - 8861